forecast

Vaccine research turns to mRNA for stability and speed

Sean noted that cancer and rare-disease therapies may be cheap to design with mRNA because the same design speed used for COVID vaccines applies, so a therapy for a disease affecting only 12 people could now be worth developing.

forecastpending

Speaker

Sean Carroll

Evidence Quote

“we can relatively inexpensively create new therapies for diseases that not too many people have... you wouldn't do that for a disease that only 12 people had in the world. Now, maybe you can.”

Source

357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics— Sean Carroll's Mindscape
Created: 11/17/2026, 7:10:08 AM

Your notes

Loading notes...